Blood Pressure Drug May Help Reduce Cardiac Iron Overload in Thalassemia Patients
A meta-analysis of seven randomized controlled trials suggests that adding amlodipine to standard iron chelation therapy may significantly lower heart and systemic iron levels in patients with transfusion-dependent thalassemia.
Key points
- Combining amlodipine with standard iron chelation significantly reduced serum ferritin and heart iron levels at 6 and 12 months.
- Myocardial T2* MRI measurements improved significantly after 12 months of combination therapy.
- The findings are limited by small trial sizes and small overall study counts, requiring confirmation in larger trials.
Adding the calcium channel blocker amlodipine to standard iron chelation therapy may help reduce iron accumulation in the heart and bloodstream among patients with transfusion-dependent thalassemia, according to a systematic review and meta-analysis conducted by researchers from institutions in Egypt and Saudi Arabia.
Key Trial Findings
The research team analyzed data from seven randomized controlled trials published between 2013 and 2022, with sample sizes ranging from 15 to 64 participants. At six months, patients receiving adjunctive amlodipine alongside standard chelation therapy experienced significant reductions in serum ferritin levels and myocardial iron concentration compared to control groups. By 12 months, the combined regimen maintained significant decreases in heart iron burden and serum ferritin, while also showing significant improvements in myocardial T2* scan measurements. No significant differences were observed in liver iron concentration or left ventricular ejection fraction at either interval.
Clinical Significance and Limitations
Excessive iron accumulation, particularly cardiac siderosis, represents a primary cause of illness and mortality in individuals requiring chronic blood transfusions. Although these results indicate that amlodipine could potentially support existing chelation protocols to protect cardiac tissue, the authors emphasized that the evidence remains preliminary. The analysis was constrained by a small number of eligible trials, modest sample sizes, and methodological variation across the evaluated studies.
What to know: Amlodipine is an established medication widely prescribed for high blood pressure, but its role in treating iron overload is still under clinical evaluation. Individuals managing thalassemia should always consult their hematologist or primary physician before making any changes to their treatment regimen.
Source Nature Health Sciences — nature.com/articles/s41598-026-70365-0 ↗
Read next
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🧠Mind & Mental HealthThe Role of Daily Mobility Training in Managing Sedentary Tension
A two-week personal trial suggests that incorporating short, daily mobility exercises may help alleviate stiffness associated with sedentary desk work. Experts note that …
🧠Mind & Mental HealthNew Theoretical Framework Explores Memory Formation and Dementia
Researchers have proposed a new model suggesting the brain's limbic system functions similarly to generative AI, potentially offering a new way to understand and classify…